vida: extract claims from 2025-07-apa-monitor-glp1-mental-health-effects

- Source: inbox/queue/2025-07-apa-monitor-glp1-mental-health-effects.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge.md

@@ -11,7 +11,7 @@ sourced_from: health/2025-xx-neda-anad-glp1-eating-disorders-clinical-guidance.m
 scope: structural
 sourcer: NEDA/ANAD
 supports: ["ai-telehealth-glp1-prescribing-commoditizes-at-scale-but-generates-systematic-safety-and-fraud-failures"]
-related: ["the-mental-health-supply-gap-is-widening-not-closing", "ai-telehealth-glp1-prescribing-commoditizes-at-scale-but-generates-systematic-safety-and-fraud-failures", "glp-1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support", "glp1-pre-treatment-eating-disorder-screening-recommended-not-required", "glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive", "glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge", "neda", "anad", "glp1-eating-disorder-screening-lacks-reimbursement-infrastructure-despite-identified-risk-population"]
+related: ["the-mental-health-supply-gap-is-widening-not-closing", "ai-telehealth-glp1-prescribing-commoditizes-at-scale-but-generates-systematic-safety-and-fraud-failures", "glp-1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support", "glp1-pre-treatment-eating-disorder-screening-recommended-not-required", "glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive", "glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge", "neda", "anad", "glp1-eating-disorder-screening-lacks-reimbursement-infrastructure-despite-identified-risk-population", "glp1-eating-disorder-screening-protocol-scoff-plus-history-plus-behavioral-assessment-recommended-for-pre-treatment-risk-stratification", "glp1-atypical-anorexia-screening-gap-creates-invisible-high-risk-population"]
 ---
 
 # GLP-1 eating disorder screening gap is structural capacity failure not clinical knowledge deficit because professional society guidance requires tri-specialist care teams unavailable in primary care settings where most prescriptions originate
@@ -73,3 +73,10 @@ Dr. DeCaro and Dr. Dennis provide clinical expert consensus that screening proto
 **Source:** STAT News, April 27, 2026
 
 Expert assessment that healthcare system is 'unprepared for this coming wave' of eating disorder cases suggests infrastructure gap extends beyond screening protocols to treatment capacity. The 420,000 person projection (1.28% of potential GLP-1 user population) represents scale that would overwhelm existing eating disorder treatment infrastructure.
+
+
+## Extending Evidence
+
+**Source:** APA Monitor on Psychology, July/August 2025
+
+APA Monitor coverage in July 2025 signals that the psychological professional community formally engaged with GLP-1 mental health effects 9 months before mainstream public awareness. Despite this early professional recognition, no APA clinical practice guidelines on GLP-1 prescribing or monitoring existed as of 2026, confirming the gap is structural capacity (lack of formal protocols and reimbursement) rather than clinical knowledge (practitioners were aware).

inbox/archive/health/2025-07-apa-monitor-glp1-mental-health-effects.md

@@ -7,10 +7,13 @@ date: 2025-07-01
 domain: health
 secondary_domains: []
 format: article
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-05-06
 priority: medium
 tags: [GLP-1, semaglutide, mental-health, anhedonia, depression, psychiatric-safety, APA, psychology]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content